HALKUFF DAWN 4
4 · Xeris Biopharma Holdings, Inc. · Filed Nov 21, 2023
Insider Transaction Report
Form 4
HALKUFF DAWN
Director
Transactions
- Purchase
Common Stock
2023-11-20$1.84/sh+5,410$9,954→ 5,410 total(indirect: By Trust)
Holdings
- 57,500
Common Stock
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.